With reference to the subject captioned and in compliance with Regulation 30 read with Schedule III and Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please note that the Board of Directors of the Company at their meeting held today i.e. Friday, January 31, 2025, inter-alia: 1. Approval of Un-audited Standalone and Consolidated Financial Results for the quarter and nine months ended December 31, 2024; and 2. Allotment of Equity Shares on conversion of warrants on Preferential Basis.